Spyre Therapeutics SYRE
NASDAQ SYRE
$90.33 -2.00 (-2.17%)
At close: Oct 23, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Short-term Investments (2015 - 2026)

Updated

Spyre Therapeutics' Short-term Investments was $983.34 million in Q2 2026, up 121.0% from $444.92 million a year earlier and up 52.6% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Short-term Investments (2015 - 2026) Analysis & Trends

At the end of FY2025, Short-term Investments at Spyre Therapeutics came in at $670.81 million, up 30.6% from FY2024.

  • Short-term Investments has now increased for three consecutive years, with a five-year compound annual growth rate of 64.2% (FY2020 to FY2025).
  • In earlier years, Short-term Investments was $513.67 million in FY2024 (+241.6%), $150.38 million in FY2023 (+621.3%), $20.85 million in FY2022 (-73.3%) and $77.99 million in FY2021 (+38.8%).
  • The Q2 2026 figure marks the highest quarterly Short-term Investments in data going back to Q4 2015.
  • Compared with a year earlier, Short-term Investments has increased for eight straight quarters, with growth averaging 95.2% over the last eight quarters.
  • The best year-over-year quarter for Short-term Investments over five years was Q4 2023 (growth of 621.3%); the worst was Q1 2023 (a decline of 93.8%).
  • Per Business Quant data, SYRE's Short-term Investments in the three quarters before Q2 2026 was $644.28 million (Q1 2026), $670.81 million (Q4 2025) and $421.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn
10 Spyre Therapeutics 7.68 Bn 4.55 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 983.34 Mn
Mar 31, 2026 644.28 Mn
Dec 31, 2025 670.81 Mn
Sep 30, 2025 421.30 Mn
Jun 30, 2025 444.92 Mn
Mar 31, 2025 516.33 Mn
Dec 31, 2024 513.67 Mn
Sep 30, 2024 342.65 Mn
Jun 30, 2024 380.85 Mn
Mar 31, 2024 257.09 Mn
Dec 31, 2023 150.38 Mn
Sep 30, 2023 113.01 Mn
Mar 31, 2023 3.24 Mn
Dec 31, 2022 20.85 Mn
Sep 30, 2022 34.69 Mn
Jun 30, 2022 51.08 Mn
Mar 31, 2022 52.09 Mn
Dec 31, 2021 77.99 Mn
Sep 30, 2021 87.76 Mn
Jun 30, 2021 93.81 Mn
API Access

Spyre Therapeutics Short-term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-investments&ticker=SYRE&period=max&api_key=YOUR_API_KEY